Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
1OG7
DownloadVisualize
BU of 1og7 by Molmil
Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P.
Descriptor: BACTERIOCIN SAKACIN P
Authors:Uteng, M, Hauge, H.H, Markwick, P.R, Fimland, G, Mantzilas, D, Nissen-Meyer, J, Muhle-Goll, C.
Deposit date:2003-04-25
Release date:2003-09-22
Last modified:2011-07-13
Method:SOLUTION NMR
Cite:Three-Dimensional Structure in Lipid Micelles of the Pediocin-Like Antimicrobial Peptide Sakacin P and a Sakacin P Variant that is Structurally Stabilized by an Inserted C-Terminal Disulfide Bridge
Biochemistry, 42, 2003
1OHN
DownloadVisualize
BU of 1ohn by Molmil
Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P.
Descriptor: BACTERIOCIN SAKACIN P
Authors:Uteng, M, Hauge, H.H, Markwick, P.R, Fimland, G, Mantzilas, D, Nissen-Meyer, J, Muhle-Goll, C.
Deposit date:2003-05-28
Release date:2003-09-22
Last modified:2011-07-13
Method:SOLUTION NMR
Cite:Three-Dimensional Structure in Lipid Micelles of the Pediocin-Like Antimicrobial Peptide Sakacin P and a Sakacin P Variant that is Structurally Stabilized by an Inserted C-Terminal Disulfide Bridge
Biochemistry, 42, 2003
1OHM
DownloadVisualize
BU of 1ohm by Molmil
Sakacin P variant that is structurally stabilized by an inserted C-terminal disulfide bridge.
Descriptor: BACTERIOCIN SAKACIN P
Authors:Uteng, M, Hauge, H.H, Markwick, P.R, Fimland, G, Mantzilas, D, Nissen-Meyer, J, Muhle-Goll, C.
Deposit date:2003-05-28
Release date:2003-09-22
Last modified:2011-07-13
Method:SOLUTION NMR
Cite:Three-Dimensional Structure in Lipid Micelles of the Pediocin-Like Antimicrobial Peptide Sakacin P and a Sakacin P Variant that is Structurally Stabilized by an Inserted C-Terminal Disulfide Bridge
Biochemistry, 42, 2003
6FYK
DownloadVisualize
BU of 6fyk by Molmil
X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A
Descriptor: (2~{S})-4-methyl-1-[5-(3-methyl-2~{H}-indazol-5-yl)pyridin-3-yl]oxy-pentan-2-amine, Dual specificity protein kinase CLK2
Authors:Kallen, J.
Deposit date:2018-03-12
Release date:2018-07-18
Last modified:2024-01-17
Method:X-RAY DIFFRACTION (2.39 Å)
Cite:X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6FYL
DownloadVisualize
BU of 6fyl by Molmil
X-ray structure of CLK2-KD(136-496)/CX-4945 at 1.95A
Descriptor: 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid, Dual specificity protein kinase CLK2
Authors:Kallen, J.
Deposit date:2018-03-12
Release date:2018-07-18
Last modified:2024-01-17
Method:X-RAY DIFFRACTION (1.95 Å)
Cite:X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6FYV
DownloadVisualize
BU of 6fyv by Molmil
X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A
Descriptor: 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid, Dual specificity protein kinase CLK4, SULFATE ION
Authors:Kallen, J.
Deposit date:2018-03-12
Release date:2018-07-18
Last modified:2024-01-17
Method:X-RAY DIFFRACTION (2.46 Å)
Cite:X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6FYO
DownloadVisualize
BU of 6fyo by Molmil
X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A
Descriptor: 6-~{tert}-butyl-~{N}-[6-(1~{H}-pyrazol-4-yl)-1~{H}-imidazo[1,2-a]pyridin-2-yl]pyridine-3-carboxamide, Dual specificity protein kinase CLK1, SULFATE ION
Authors:Kallen, J.
Deposit date:2018-03-12
Release date:2018-07-18
Last modified:2024-01-17
Method:X-RAY DIFFRACTION (2.32 Å)
Cite:X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6FYR
DownloadVisualize
BU of 6fyr by Molmil
X-RAY STRUCTURE OF CLK3-KD(GP-[275-632], NON-PHOS.)/Cpd-2 AT 1.42A
Descriptor: 6-~{tert}-butyl-~{N}-[6-(1~{H}-pyrazol-4-yl)-1~{H}-imidazo[1,2-a]pyridin-2-yl]pyridine-3-carboxamide, Dual specificity protein kinase CLK3
Authors:Kallen, J.
Deposit date:2018-03-12
Release date:2018-07-18
Last modified:2024-01-17
Method:X-RAY DIFFRACTION (1.42 Å)
Cite:X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6FYP
DownloadVisualize
BU of 6fyp by Molmil
X-RAY STRUCTURE OF CLK3-KD(GP-[275-632], NON-PHOS.)/CX-4945 AT 2.29A
Descriptor: 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid, Dual specificity protein kinase CLK3
Authors:Kallen, J.
Deposit date:2018-03-12
Release date:2018-07-18
Last modified:2024-01-17
Method:X-RAY DIFFRACTION (2.29 Å)
Cite:X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6FYI
DownloadVisualize
BU of 6fyi by Molmil
X-ray Structure of CLK2-KD(130-496)/TG003 at 2.6A
Descriptor: (1~{Z})-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one, Dual specificity protein kinase CLK2
Authors:Kallen, J.
Deposit date:2018-03-12
Release date:2018-07-18
Last modified:2024-01-17
Method:X-RAY DIFFRACTION (2.6 Å)
Cite:X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon